Demand for Poly-pill Products to Scale New Heights as Studies Focus on Reducing Side Effects
The healthcare sector worldwide continues to embrace new medical treatments, therapies, and drugs. At present, cardiovascular diseases are considered to be the leading causes of death worldwide due to which, research and development activities pertaining to the treatment of an array of cardiovascular diseases have gained considerable momentum. Although international guidelines advocate the adoption of statins, aspirin, and pressure-lowering therapy for individuals with a history of cardiovascular condition, the adoption of these medications is relatively low. Multiple clinical trials have revealed that the combination of these medications with a polypill product is likely to improve systolic blood pressure, adherence, and low-density lipoprotein cholesterol.
Although the demand for polypill products is expected to witness steady growth during the forecast period, mounting safety concerns surrounding the use of polypill products could hamper its adoption. Research and development activities within the polypill products market are largely focused on minimizing the side effects and investigating the consequences of non-adherence to polypill products in comparison with individual medication. Thus, due to a surge in the prevalence of chronic diseases across the world, the demand for polypill products is projected to witness notable growth in the coming years. At the back of these factors, the global polypill products market is expected to reach market value of ~US$ 35 Bn by the end of 2027.
To know the scope of our report Get a Sample on Polypill Products Market
Efforts to Improve Medication Adherence to Increase Demand for Polypill Products
High cholesterol and high blood pressure are some of the leading causes of cardiovascular deaths worldwide. Although there are treatments and medications available to address these conditions, they are left undertreated particularly in the underdeveloped and developing regions. The lack of adequate prescription and poor medication adherence are some of the leading factors as to why high cholesterol and high blood pressure are undertreated across the world. One of the potential methods to enhance medication adherence that is currently being investigated is the combination of one or more medications into a polypill.
Get a glimpse of the in-depth analysis through our Report Brochure
Some of the major factors that are likely to boost the adoption of polypill products during the forecast period include lower dosage of different medications, which, in turn are projected to reduce the side effects. In addition, players operating in the current polypill products market are expected to advertise polypill products as an easy to remember medication and convenience as the USP to improve their sales. In addition, polypill products have also emerged as a cost-effective medication alternative and likely to replace therapies that require multiple medications.
Despite factors that are likely to increase the demand for polypill products in the coming years, the potential side-effects, overtreatment, undesirable interaction of different medication, and low dosing flexibility are some of the factors that could hinder the demand.
- Latest Posts